Luo, Y., Paul, S. K., Zhou, X., Chang, C., Chen, W., Guo, X., . . . Wang, H. Rationale, Design, and Baseline Characteristics of Beijing Prediabetes Reversion Program: A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Lifestyle Intervention and/or Pioglitazone in Reversion to Normal Glucose Tolerance in Prediabetes. Wiley.
Chicago Style (17th ed.) CitationLuo, Yingying, Sanjoy K. Paul, Xianghai Zhou, Cuiqing Chang, Wei Chen, Xiaohui Guo, Jinkui Yang, Linong Ji, and Hongyuan Wang. Rationale, Design, and Baseline Characteristics of Beijing Prediabetes Reversion Program: A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Lifestyle Intervention And/or Pioglitazone in Reversion to Normal Glucose Tolerance in Prediabetes. Wiley.
MLA (9th ed.) CitationLuo, Yingying, et al. Rationale, Design, and Baseline Characteristics of Beijing Prediabetes Reversion Program: A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Lifestyle Intervention And/or Pioglitazone in Reversion to Normal Glucose Tolerance in Prediabetes. Wiley.